Sugi Predict

Sugi Predict / Compounds / SCHEMBL1316783

SCHEMBL1316783

SCHEMBL1316783

CCOc1nc(C(=O)NCC2CCN(C(C)(C)c3ccc(-c4ccccc4)cc3)CC2)cc(N)c1C#N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 18/20 0.57
▸ MAPK9 P45984 13/20 0.57
▸ MAPK10 P53779 7/20 0.57
▸ RPS27 P42677 4/20 0.57
▸ CSF1R P07333 5/20 0.52
▸ MAPK1 P28482 5/20 0.52
▸ PRKD2 Q9BZL6 5/20 0.52
▸ AKT1 P31749 3/20 0.52
▸ ROCK2 O75116 3/20 0.52
▸ CSNK1D P48730 3/20 0.52
▸ DYRK3 O43781 2/20 0.52
▸ PRKD3 O94806 2/20 0.52
▸ RPS6KB1 P23443 2/20 0.52
▸ KIT P10721 1/20 0.52
▸ BLK P51451 1/20 0.52
▸ TYRO3 Q06418 1/20 0.52
▸ MAP4K2 Q12851 1/20 0.52
▸ ROCK1 Q13464 1/20 0.52
▸ MELK Q14680 1/20 0.52
▸ MARK2 Q7KZI7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1315006 0.86 MAPK8 (0.61) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL1314053 0.83 MAPK8 (0.61) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL1145057 0.83 MAPK8 (0.67) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL1314174 0.82 MAPK8 (0.60) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL1315508 0.82 MAPK8 (0.57) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL13514301 0.82 MAPK8 (0.70) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL1145397 0.81 MAPK8 (0.59) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL1145177 0.80 MAPK8 (0.59) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL12113069 0.80 MAPK8 (0.56) MAPK8MAPK9MAPK10RPS27CSF1R
SCHEMBL1314440 0.80 MAPK8 (0.55) MAPK8MAPK9MAPK10RPS27CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 — — US disclosed
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 — — US disclosed
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 — — US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 — — US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 — — US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 — — US disclosed
EP-2375899-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF Array Biopharma, Inc. (US) 2011-10-19 — — EP disclosed
WO-2010080864-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2010-07-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF NOS1, NOS2, ASS1 MAPK8 3189/4885MAPK9 1568/4885MAPK10 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.